Page last updated: 2024-08-24

lamivudine and Viremia

lamivudine has been researched along with Viremia in 135 studies

Research

Studies (135)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	29 (21.48)	18.2507
2000's	76 (56.30)	29.6817
2010's	24 (17.78)	24.3611
2020's	6 (4.44)	2.80

Authors

Authors	Studies
de la Mora, L; García, F; Llibre, JM; Noguera-Julián, M; Paredes, R; Parera, M; Revollo, B; Viñuela, L	1
Cassidy, T; Flowers, T; Goemaere, E; Griesel, R; Hill, A; Jackson, A; Keene, CM; Maartens, G; Meintjes, G; Ngwenya, O; Omar, Z; Sayed, K; Van Zyl, G; Zhao, Y	1
Akodu, J; Ambrose, A; Barber, TJ; Bowman, C; Flores, K; Hart, J; Hunter, A; Kanitkar, T; Simoes, P	1
Cao, B; Ding, P; Huang, F; Huang, Y; Jiang, J; Jiang, T; Liu, M; Yu, Q; Yuan, T; Zhou, X	1
Amponsah-Dacosta, E; Blackard, JT; Burnett, RJ; Gededzha, MP; Kyaw, T; Lukhwareni, A; Mphahlele, MJ; Selabe, SG	1
Boye, CS; Chemin, I; Cissé, AM; Cohen, D; Diop-Ndiaye, H; Dramé, A; Kébé-Fall, K; Laborde-Balen, G; Lô, G; Mboup, S; Ndiaye, AJS; Pujol, FH; Taverne, B; Touré-Kane, C; Toyé, RM	1
Appiah, LT; Beloukas, A; Chadwick, D; Geretti, AM; Phillips, RO; Ruggiero, A; Sarfo, FS; Smith, C; Stockdale, AJ; Villa, G	1
Foaud, HM; Gmal El Din, A; Mahmoud, F; Maklad, S	1
Agarwal, K; Bruce, M; Byrne, R; Carey, I; Childs, K; Joshi, D; Taylor, C	1
Perelson, AS; Zhang, J	1
Arzumanyan, A; Clayton, MM; Feitelson, MA; Goldmann, S; Li, J; Liu, B; Ren, Q; Schinazi, RF; Wang, Z; Wu, G; Zhang, F; Zhang, Y	1
Alegría-Motte, C; Gómez García, M; González-Artacho, C; Rodríguez Sicilia, MJ	1
Gilks, CF; Goodall, RL; Gupta, RK; Kaleebu, P; Kityo, C; Lyagoba, F; Mugarura, L; Munderi, P; Pillay, D; Ranopa, M	1
Anino, E; Choge, JK; Khayeka-Wandabwa, C; Kweka, EJ; Ngemu, EK; Oyoo-Okoth, E	1
Amorosa, VK; Chang, KM; De La Torre, P; Frank, I; Gross, R; Hafkin, JS; Kostman, JR; Lo Re, V; Localio, AR; Mounzer, K; Osborn, MK; Stern, JJ	1
Gerlich, WH	1
Berkley, EM; Dunkelberg, JC; Leslie, KK; Thiel, KW	1
Ahishali, E; Doganay, L; Enc, FY; Erdem, E; Gonen, C; Gunduz, F; Ozdogan, O; Sokmen, M; Tuncer, I; Yegin, EG	1
Bravo, I; Clotet, B; Llibre, JM; Martin-Iguacel, R; Ornelas, A; Paredes, R; Puig, J; Santos, JR	1
Archampong, TN; Boamah, I; Flanigan, T; Gillani, FS; Kenu, E; Kwara, A; Lartey, M; Obo-Akwa, A; Sagoe, KW; Yang, H	1
Gaeta, GB; Pontarelli, A; Rizzo, V; Stanzione, M; Stornaiuolo, G	1
Fang, Y; Hu, Q; Yang, DL; Zhang, XY; Zhang, ZH; Zhang, ZM	1
Brett, S; Chokshi, S; Cooksley, H; Evans, A; Naoumov, NV; Nathwani, A; Phillips, S; Puranik, S; Riva, A	1
Hsu, R; Lanier, ER; Oie, KL; Pappa, KA; Ross, LL; Rouse, EG	1
Arrifin, N; Audsley, J; Ayres, A; Bartholomeusz, A; Crowe, SM; Lewin, SR; Locarnini, SA; Mijch, A; Sasadeusz, J; Yuen, LK	1
Benech, H; Bourry, O; Brochard, P; Calvo, J; Dereudre-Bosquet, N; Kazanji, M; Le Grand, R; Makuwa, M; Martinon, F; Souquiere, S	1
Brancaccio, G; Gaeta, GB; Nardiello, S; Precone, V; Sgrò, G; Stornaiuolo, G	1
Andreotti, M; Antonelli, G; Ceccarelli, G; d'Ettorre, G; Massetti, P; Mastroianni, CM; Rizza, C; Turriziani, O; Vella, S; Vullo, V	1
Cohen, C; DeJesus, E; Elion, R; Gerondelis, P; Ha, B; Horton, J; Lanier, ER; Ross, LL; Rouse, E	1
Alteri, C; Angelico, M; Bernassola, M; Bertoli, A; Cappiello, G; Cassola, G; Ceccherini-Silberstein, F; De Sanctis, GM; Feasi, M; Gallinaro, V; Gori, C; Gubertini, G; Longo, R; Marcuccilli, F; Micheli, V; Parruti, G; Perno, CF; Romano, S; Salpini, R; Spanò, A; Svicher, V; Ursitti, A; Visca, M	1
Abrams, EJ; Coovadia, A; Hu, CC; Hunt, G; Kuhn, L; Martens, L; Meyers, T; Morris, L; Sherman, G; Stehlau, R; Tsai, WY	1
Benech, H; Bourry, O; Dereuddre-Bosquet, N; Durand-Gasselin, L; Le Grand, R; Mannioui, A; Roques, P; Roucairol, C; Sellier, P	1
Bruzzone, B; Caligiuri, P; Di Biagio, A; Icardi, G; Rosso, R; Taramasso, L; Viscoli, C	1
An, H; Byun, KS; Hyun, JJ; Jung, ES; Kang, HS; Kim, CD; Kim, DJ; Kim, JH; Kim, TH; Lee, HS; Ryu, HS; Seo, YS; Um, SH; Yeon, JE; Yim, HJ; Yoon, E	1
Allweiss, L; Bierwolf, J; Dandri, M; Lütgehetmann, M; Matthes, E; Petersen, J; Pollok, JM; Volz, T; Warlich, M	1
Berg, T; Bock, FJ; Deterding, K; Feucht, HH; Hüppe, D; Möller, B; Trojan, J; van Bömmel, F; Wasmuth, HE; Wedemeyer, H	1
Fung, J; Hung, IF; Lai, CL; Liu, K; Seto, WK; Wong, DK; Yuen, JC; Yuen, MF	1
Chantawuttinan, T; Dabtham, K; Hawkins, D; Hill, AM; Kanshana, S; Moyle, GJ; Sirichthaporn, P; Somburanasin, P; Supajatura, V; Vithayasai, V; Wattanatchariya, N	1
Bon, I; Borderi, M; Furlini, G; Gibellini, D; La Placa, M; Monari, P; Re, MC; Schiavone, P; Vitone, F	1
Brault, C; Chennebault, JM; Loison, J; Payan, C; Peigne, M	1
Chroni, E; Karatza, CL; Papapetropoulos, S; Paschalis, C; Thomopoulos, C	1
Ayres, A; Bartholomeusz, A; Cooley, L; Crowe, S; Lewin, S; Locarnini, S; Mijch, A; Sasadeusz, J	1
Albert, J; Blaxhult, A; Brandin, E; Broström, C; Gisslen, M; Gyllensten, K; Hagberg, L; Lindborg, L; Tuvesson, B	1
Barcena Marugan, R; Cid Gomez, L; Lopez Serrano, P	1
Ganem, D; Prince, AM	1
Berr, F; Etzrodt, G; Klecker, C; Liebert, UG; Maier, M; Oesen, U; Schiefke, I; Tannapfel, A	1
Cote, PJ; Delaney, WE; Gerin, JL; Jacob, JR; Korba, BE; Tennant, BC; Toshkov, I	1
Barbon, V; Gaia, S; Lagget, M; Marzano, A; Rizzetto, M	1
Havlir, DV; Ignacio, CC; Koelsch, KK; Lu, B; Margot, N; Miller, MD; Strain, MC; Wong, JK	1
Choi, BC; Lei, XY; Li, D; Men, K; Xu, DZ; Yan, YP; Zhang, JX	1
Bozdayi, AM; Bozkaya, H; Cetinkaya, H; Cinar, K; Erden, E; Erkan, O; Idilman, R; Tüzün, A; Uzun, Y; Uzunalimoglu, O; Yurdaydin, C	1
Bower, M; Davies, E; Gazzard, B; Latham, V; Mandalia, S; Michailidis, C; Nelson, M; Stebbing, J	1
Amel, EB; Amel, LO; Amine, SM; Asma, J; Fethi, T; Mohamed, C; Mounira, G; Taoufik, BC	1
Angarano, G; Fazio, V; Palumbo, E; Saracino, A; Scotto, G; Tartaglia, A	1
Chokshi, S; Mullerova, I; Naoumov, NV; Rice, S; Rigopoulou, EI; Suri, D; Tedder, RS; Williams, R	1
Chayama, K; Fujimoto, Y; Hiraga, N; Imamura, M; Iwao, E; Noguchi, C; Ochi, H; Oga, H; Takahashi, S; Takaishi, H; Tateno, C; Tsuge, M; Yoshizato, K	1
Black, FT; Jørgensen, LB; Kjems, J; Mohey, R; Møller, BK; Obel, N	1
Ayres, A; Bartholomeusz, A; Cooper, DA; Dore, GJ; Lewin, S; Locarnini, S; Matthews, GV; Sasaduesz, J; Seaberg, E; Thio, CL	1
Funk, A; Gerlich, WH; Hartmann, H; Helm, M; Olotu, C; Rockstroh, JK; Schildgen, O; Sirma, H; Wend, UC; Will, H; Willems, WR	1
Antunes, F; Chiesi, A; Goebel, FD; Katlama, C; Knysz, B; Ledergerber, B; Lundgren, JD; Mocroft, A; Phillips, AN; Reiss, P	1
Allice, T; Cerutti, F; Colucci, G; Franchello, A; Gabella, S; Ghisetti, V; Marzano, A; Pittaluga, F; Varetto, S	1
Chang, ML; Hsu, CW; Liaw, YF; Yeh, CT	1
Brun, SC; Coffin, JM; Davey, RT; Dewar, R; Hanna, GJ; Kempf, DJ; King, MS; Kovacs, JA; Liu, S; Maldarelli, F; Mellors, JW; Metcalf, JA; Mican, J; Palmer, S; Polis, MA; Rehm, C; Rock-Kress, D; Wiegand, A	1
Calleja, JL; Peñas, B	1
Bae, SH; Chang, UI; Choi, JY; Jang, JW; Lee, YC; Sun, HS; Wie, SH; Yang, JM; Yoon, SK	1
Bakulin, I; Balakirev, E; Baranova, F; Chervinko, V; Kovalchuk, A; Novozhenov, V; Stahanova, V; Stanke, A; Stenina, I; Zolotarevsky, V; Zubkin, M	1
Bertelsen, L; Jakobsen, MR; Laursen, A; Mohey, R; Obel, N; Ostergaard, L; Tolstrup, M	1
Bonino, F; Brunetto, MR; Ciccorossi, P; Coco, B; Colombatto, P; Flichman, D; Maina, AM; Moriconi, F; Oliveri, F; Sacco, R	1
Giry, C; Hebert, JC; Lartigau-Roussin, C; Malvy, D; Pettinelli, ME; Receveur, MC	1
Ansari, AW; Heiken, H; Schmidt, RE	1
Akdoğan, M; Bozdayi, AM; Bozkaya, H; Cetinkaya, H; Erden, E; Erkan-Esin, O; Gerin, JL; Karaaslan, H; Onder, FO; Ozden, A; Schinazi, RF; Sentürk, H; Uzunalimoğlu, O; Yalçin, K; Yurdaydin, C	1
Buronfosse, T; Chevallier, M; Cova, L; Pradat, P; Thermet, A; Trepo, C; Werle-Lapostolle, B; Zoulim, F	1
Boucher, CA; Cammack, N; Hill, A; Ingrand, D; Loveday, C; Robert, C; Weber, J	1
Boehme, R; Bonhoeffer, S; Hill, AM; McDade, H; Nowak, MA; Thomas, HC	1
Costes, O; Lafeuillade, A; Poggi, C; Profizi, N; Tamalet, C	1
Bain, VG; Fischer, KP; Kneteman, NM; Ma, MM; Tipples, GA; Tyrrell, DL	1
Slavkin, HC	1
Belohradsky, BH; Eberle, J; Gürtler, L; Notheis, G; Sölder, B; Wintergerst, U	1
Cao, Y; Essunger, P; Ho, DD; Hurley, A; Markowitz, M; Perelson, AS; Saksela, K; Vesanen, M	1
Fantini, J; Lafeuillade, A; Poggi, C; Tamalet, C; Yahi, N	1
Günthard, HF; Havlir, DV; Hezareh, M; Ignacio, CC; Richman, DD; Spina, CA; Wong, JK	1
Goldstein, H; Katopodis, NF; Kim, A; Kollmann, TR; Pettoello-Mantovani, M; Raker, C; Wiltshire, H; Yurasov, S	1
Blanchard, G; Blum, L; Calvo, F; Danne, O; Lebbé, C; Morel, P; Pellet, C; Vérola, O	1
Gerin, JL; Hurwitz, SJ; Korba, BE; Schinazi, RF; Tennant, BC	1
Clerici, M; Ferrante, P; Rusconi, S; Saresella, M; Viganó, A	1
Al-Shboul, Q; Day, RD; Fan, Z; Huang, XL; Liebmann, JM; McMahon, DK; Mellors, JW; Riddler, SA; Rinaldo, CR	1
Arazi, J; Ben-Moshe, O; Berr, S; Burakova, T; Dagan, S; Eid, A; Eren, R; Galun, E; Gillard, J; Ilan, E; Jurim, O; Lubin, I; Mansour, TS; Neville, L; Nussbaum, O; Reisner, Y; Shouval, D; Yuen, L	1
Binley, JM; Cao, Y; Chaudhry, MR; Frankel, S; Heath-Chiozzi, M; Ho, DD; Hurley, A; J, X; Jin, X; Leonard, JM; Markowitz, M; Moore, JP; Nixon, DF; Racz, P; Talal, A; Tenner-Racz, K; Vesanen, M; Yaman, M	1
Carr, A; Cooper, DA; Cunningham, PH; Grey, P; Jaramillo, AB; Kaufmann, GR; Kelleher, AD; Smith, D; Vizzard, J; Wright, R; Zaunders, JJ	1
Chêne, G; Cotte, L; Debord, T; Decazes, JM; Ferchal, F; Journot, V; Madelaine, I; Molina, JM; Pellegrin, I; Rancinan, C; Sombardier, MN	1
Goulder, PJ; Jones, NG; Kalams, SA; Ogg, GS; Shea, AK; Trocha, AK; Walker, BD	1
Hogg, RS; Jahnke, N; Montaner, JS; O'Shaughnessy, M; Yip, B	1
Bourne, EJ; Brown, NA; Condreay, LD; Crowther, LM; Dienstag, JL; Gauthier, J; Lutz, MW	1
Asjö, B; Dyrhol-Riise, AM; Olofsson, J; Voltersvik, P	1
Arrizabalaga, J; Clotet, BG; Cruceta, A; Dalmau, D; Gallart, T; García, F; Gatell, JM; Gomez-Sirvent, JL; Grau, I; Knobel, H; Miró, JM; O'Brien, WA; Podzamczer, D; Pumarola, T; Romeu, J; Sambeat, MA	1
Antunes, F; Brown, DJ; Clumeck, N; Fetter, A; Haubrich, R; Kahl, L; Lang, W; Pagano, G; Richman, D; Schooley, R; Sereni, D; Stein, A; Thompson, M; van der Ende, ME	1
Arts, EJ; García Lerma, JG; Heneine, W; Mas, A; Quiñones-Mateu, ME; Soriano, V	1
Burroughs, NJ; Mutimer, D; Pillay, D	1
Campi, G; Casorati, G; Corey, L; Demarest, JF; Kaufmann, D; Lazzarin, A; Lenge, C; Pantaleo, G; Rizzardi, GP; Soudeyns, H; Tambussi, G	1
Asjö, B; Dyrhol-Riise, AM; Olofsson, J; Røsok, BI; Voltersvik, P	1
Bart, PA; Chapuis, A; De Boer, RJ; Fox, CH; Halkic, N; Hoover, S; Lange, JM; Lazzarin, A; Miller, V; Notermans, DW; Pantaleo, G; Perrin, L; Rizzardi, GP; Staszewski, S; Tambussi, G	1
Cote, P; Gerin, JL; Hornbuckle, W; Korba, BE; Schinazi, R; Tennant, BC	1
Bréchot, C; Chrétien, Y; Fontaine, H; Kreis, H; Legendre, C; Pol, S; Poupon, RE; Thiers, V; Zylberberg, H	1
Bray, D; Clerici, M; Colombo, F; Dix, LP; Fusi, ML; Milazzo, F; Piconi, S; Rizzardini, G; Trabattoni, D	1
Chodakewitz, JA; Condra, JH; Emini, EA; Eron, JJ; Gonzalez, C; Gulick, RM; Havlir, D; Isaacs, R; Jonas, L; McMahon, D; Meibohm, A; Mellors, JW; Richman, DD; Valentine, FT	1
Chieco-Bianchi, L; De Rossi, A; Del Mistro, A; Giaquinto, C; Zamarchi, R	1
de Man, RA; Heijtink, RA; Niesters, HG; Schalm, SW; van Nunen, AB	1
Cote, P; Gangemi, JD; Gerin, JL; Hornbuckle, W; Korba, BE; Schinazi, R; Tennant, BC	1
Aoki, M; Haga, H; Miyano, S; Saito, T; Shinzawa, H; Takahashi, T; Terui, Y; Watanabe, H	1
Pozo, F; Rivero, A; Serrano, R; Tenorio, A; Torre-Cisneros, J; Vidal, E	1
Carter, LM; Ellis, BA; Peters, BS; Wolstencroft, RA	1
Busch, M; Hecht, FM; Kahn, J; Levy, JA; Martinez-Marino, B; Ong, JC; Stranford, SA	1
Abbate, I; Antonelli, G; Capobianchi, MR; D'Offizi, G; Dianzani, F; Galati, V; Pandolfi, F; Pierdominici, M; Turriziani, O	1
Achilli, G; Bruno, R; Debiaggi, M; Filice, G; Patruno, SF; Pistorio, A; Romero, E; Sacchi, P; Zara, F	1
Cheng, YC; Chevallier, M; Guerret, S; Hantz, O; Jamard, C; King, I; Le Guerhier, F; Peyrol, S; Pichoud, C; Trépo, C; Zoulim, F	1
Brown, AJ; Emini, E; Eron, J; Fiscus, S; Frost, SD; Gamagami, R; Gulick, R; Günthard, HF; Haase, A; Havlir, DV; Ignacio, CC; Isaacs, R; Jonas, L; Meibohm, A; Mellors, J; Richman, DD; Schleif, W; Valentine, F; Wong, JK; Zhang, ZQ	1
Achilli, G; Bruno, R; De Santolo, A; Debiaggi, M; Filice, G; Maserati, R; Pistorio, A; Romero, E; Sacchi, P; Spinillo, A; Zara, F	1
Altisent, C; Bravo, R; García-Samaniego, J; Gómez-Cano, M; González-Lahoz, J; Ruiz, I; Soriano, V	1
Japour, AJ	1
Chang, HE	1
Asjö, B; Berg, OG; Dyrhol-Riise, AM; Kleivbo, S; Olofsson, J; Voltersvik, P	1
Bassett, R; Collier, AC; Condra, J; Gilbert, P; Günthard, HF; Havlir, DV; Hirsch, MS; Ignacio, C; Levitan, D; Richman, DD; Tebas, P; Wong, JK	1
Carrilho, FJ; Da Fonseca, LE; Da Silva, LC; Pinho, JR; Sitnik, R	1
Borrás-Cuesta, F; Condreay, L; Cullen, JM; Hervás-Stubbs, S; Lasarte, JJ; Prieto, J; Sarobe, P; Vivas, I	1
Chadapaud, S; Chouraqui, M; Delbeke, E; Hittinger, G; Lafeuillade, A; Poggi, C	1
Pol, S	1
Andersson, J; Cooper, D; Goh, LE; Hoen, B; Janossy, G; Kinloch, S; Lampe, F; Perrin, L; Tilling, R; Tsoukas, C; Zaunders, J	1
Cai, W; Cao, Y; Ding, Y; Gao, M; Li, L; Mei, S; Zhang, F	1
Adamek, J; Bolewska, B; Cianciara, J; Czajka, B; Gonciarz, Z; Gładysz, A; Juszczyk, J; Król, F; Kryczka, W; Mazur, W; Nazzal, K; Swietek, K	1
Gazzard, BG; Moyle, GJ	1
Cooper, DA; Dore, GJ	1
Perrin, L	1
Ray, SC; Sulkowski, MS; Thomas, DL	1
Dimou, E; Hadziyannis, SJ; Laras, A; Papadimitropoulos, V; Papatheodoridis, GV	1

Reviews

5 review(s) available for lamivudine and Viremia

Article	Year
Hepatitis B and C in pregnancy: a review and recommendations for care. Journal of perinatology : official journal of the California Perinatal Association, 2014, Volume: 34, Issue:12 Topics: Antiviral Agents; Breast Feeding; Cesarean Section; Contraindications; DNA, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Mass Screening; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Telbivudine; Thymidine; Viremia	2014
Hepatitis B virus infection--natural history and clinical consequences. The New England journal of medicine, 2004, Mar-11, Volume: 350, Issue:11 Topics: Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Liver Neoplasms; Viremia; Virus Replication	2004
[Entecavir: a new hope for the treatment of chronic hepatitis B]. Gastroenterologia y hepatologia, 2007, Volume: 30, Issue:5 Topics: Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; DNA, Viral; Double-Blind Method; Drug Resistance, Viral; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome; Viremia	2007
[HVB and HVC infections in nephrology]. Nephrologie, 2001, Volume: 22, Issue:6 Topics: Antiviral Agents; Comorbidity; Contraindications; Graft Rejection; Hepatitis B; Hepatitis C; Humans; Immunosuppression Therapy; Interferon-alpha; Kidney Diseases; Kidney Transplantation; Lamivudine; Liver Cirrhosis; Postoperative Complications; Renal Dialysis; Ribavirin; Vaccination; Viral Hepatitis Vaccines; Viremia	2001
The impact of HIV therapy on co-infection with hepatitis B and hepatitis C viruses. Current opinion in infectious diseases, 2001, Volume: 14, Issue:6 Topics: Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; Hepatitis B; Hepatitis C; HIV Infections; Humans; Lamivudine; Liver; Ribavirin; Viremia	2001

Trials

28 trial(s) available for lamivudine and Viremia

Article	Year
High rate of HIV resuppression after viral failure on first-line antiretroviral therapy in the absence of switch to second-line therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Volume: 58, Issue:7 Topics: Anti-HIV Agents; Dideoxynucleosides; Drug Combinations; Humans; Lamivudine; Nevirapine; Viral Load; Viremia; Zidovudine	2014
Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women. BMC research notes, 2014, Jan-21, Volume: 7 Topics: Administration, Oral; Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Counseling; Drug Administration Schedule; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Infusions, Intravenous; Kenya; Lamivudine; Medication Adherence; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Socioeconomic Factors; Viral Load; Viremia; Young Adult; Zidovudine	2014
Proportion and factors associated with Hepatitis B viremia in antiretroviral treatment naïve and experienced HIV co-infected Ghanaian patients. BMC infectious diseases, 2016, Jan-13, Volume: 16 Topics: Adolescent; Adult; Anti-HIV Agents; Antiviral Agents; Coinfection; Cross-Sectional Studies; Female; Ghana; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Tenofovir; Viral Load; Viremia; Young Adult	2016
Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial. JAMA, 2010, Sep-08, Volume: 304, Issue:10 Topics: Anti-HIV Agents; Child, Preschool; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Male; Maternal Exposure; Nevirapine; Protease Inhibitors; Pyrimidinones; RNA, Viral; Stavudine; Treatment Outcome; Viremia	2010
Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis. Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32, Issue:4 Topics: Adult; Aged; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Middle Aged; Multivariate Analysis; Republic of Korea; Viremia	2012
Safety and efficacy of saquinavir soft-gelatin capsules + zidovudine + optional lamivudine in pregnancy and prevention of vertical HIV transmission. Journal of acquired immune deficiency syndromes (1999), 2002, Aug-01, Volume: 30, Issue:4 Topics: Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Safety; Saquinavir; Thailand; United Kingdom; Viremia; Zidovudine	2002
Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a. Liver international : official journal of the International Association for the Study of the Liver, 2004, Volume: 24, Issue:2 Topics: 2-Aminopurine; Administration, Oral; Adolescent; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Famciclovir; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Middle Aged; Mutation; Recombinant Proteins; Treatment Outcome; Viral Load; Viremia	2004
Lamivudine treatment in HBeAg-negative chronic hepatitis B patients with low level viraemia. Antiviral therapy, 2005, Volume: 10, Issue:2 Topics: Adult; Alanine Transaminase; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Viremia	2005
Effects on immunological and virological outcome of patients using one protease inhibitor or one non-nucleoside reverse transcriptase inhibitor in a triple antiretroviral therapy: normal clinical practice versus clinical trial findings. Current HIV research, 2005, Volume: 3, Issue:3 Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cohort Studies; Cyclopropanes; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Male; Oxazines; Retrospective Studies; Treatment Outcome; Tunisia; Viremia; Zidovudine	2005
Clinical and virological response to adefovir dipovixil for lamivudine-resistant HBeAg-negative hepatitis B. The new microbiologica, 2005, Volume: 28, Issue:3 Topics: Adenine; Administration, Oral; Adult; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Viremia	2005
Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity. Hepatology (Baltimore, Md.), 2005, Volume: 42, Issue:5 Topics: Adjuvants, Immunologic; Adult; CD4-Positive T-Lymphocytes; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B Core Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-gamma; Interleukin-12; Lamivudine; Male; Pilot Projects; Recombinant Proteins; Reverse Transcriptase Inhibitors; T-Lymphocytes; Viremia; Virus Replication	2005
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia. PLoS pathogens, 2007, Volume: 3, Issue:4 Topics: Anti-HIV Agents; Cohort Studies; Double-Blind Method; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Longitudinal Studies; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Sensitivity and Specificity; Stavudine; Viremia; Virus Replication	2007
Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon. Journal of viral hepatitis, 2008, Volume: 15, Issue:4 Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Biopsy; Drug Therapy, Combination; Female; Hepatitis D, Chronic; Humans; Interferons; Lamivudine; Liver; Male; Middle Aged; RNA, Viral; Treatment Outcome; Viral Load; Viremia	2008
Phase I/II study of 3TC (lamivudine) in HIV-positive, asymptomatic or mild AIDS-related complex patients: sustained reduction in viral markers. The Lamivudine European HIV Working Group. AIDS (London, England), 1995, Volume: 9, Issue:12 Topics: Adult; AIDS-Related Complex; Antigen-Antibody Complex; Antiviral Agents; Dose-Response Relationship, Drug; HIV; HIV Core Protein p24; HIV Infections; HIV Seropositivity; Humans; Lamivudine; Leukocytes, Mononuclear; Male; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Viremia; Zalcitabine	1995
Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens. The Journal of infectious diseases, 1999, Volume: 179, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antigens, Bacterial; CD4-Positive T-Lymphocytes; Cell Division; Chemokines; Cytokines; Double-Blind Method; Female; HIV Antigens; HIV-1; Humans; Indinavir; Lamivudine; Male; Mitogens; RNA, Viral; Viremia; Zidovudine	1999
The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses. The Journal of infectious diseases, 1999, Volume: 179, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Drug Therapy, Combination; HIV-1; Homosexuality, Male; Humans; Lamivudine; Male; Middle Aged; Pilot Projects; Ritonavir; RNA, Viral; T-Lymphocytes, Cytotoxic; Time Factors; Viremia; Virus Replication; Zidovudine	1999
Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia. The Journal of infectious diseases, 1999, Volume: 180, Issue:2 Topics: Adult; Anti-HIV Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cohort Studies; DNA, Viral; Drug Therapy, Combination; HIV Antibodies; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Prospective Studies; RNA, Viral; T-Lymphocyte Subsets; Viremia; Zidovudine	1999
The ALBI trial: a randomized controlled trial comparing stavudine plus didanosine with zidovudine plus lamivudine and a regimen alternating both combinations in previously untreated patients infected with human immunodeficiency virus. The Journal of infectious diseases, 1999, Volume: 180, Issue:2 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Treatment Outcome; Viremia; Zidovudine	1999
Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine. The Journal of infectious diseases, 1999, Volume: 180, Issue:6 Topics: Antiviral Agents; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Genetic Variation; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Reverse Transcriptase Inhibitors; Viremia	1999
A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study. AIDS (London, England), 1999, Dec-03, Volume: 13, Issue:17 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-CD8 Ratio; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Palatine Tonsil; Ritonavir; RNA, Viral; Spain; Stavudine; Viremia; Zalcitabine; Zidovudine	1999
A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience. Amprenavir PROAB2002 Study Team. AIDS (London, England), 1999, Dec-03, Volume: 13, Issue:17 Topics: Adult; Anti-HIV Agents; Carbamates; CD4 Lymphocyte Count; Female; Furans; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nausea; RNA, Viral; Safety; Sulfonamides; Time Factors; Viremia; Zidovudine	1999
Effect of two different combinations of antiretrovirals (AZT+ddI and AZT+3TC) on cytokine production and apoptosis in asymptomatic HIV infection. Antiviral research, 2000, Volume: 46, Issue:3 Topics: Anti-HIV Agents; Apoptosis; CD4 Lymphocyte Count; CD4-CD8 Ratio; Cytokines; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Leukocytes, Mononuclear; Prospective Studies; Reverse Transcriptase Inhibitors; Th1 Cells; Viremia; Zidovudine	2000
3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine. Annals of internal medicine, 2000, Jul-04, Volume: 133, Issue:1 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Genotype; HIV; HIV Infections; Humans; Indinavir; Kidney Calculi; Lamivudine; Male; Middle Aged; RNA, Viral; Viral Load; Viremia; Zidovudine	2000
Patterns of lymphotropic herpesvirus viraemia in HIV-infected patients with Kaposi's sarcoma treated with highly active antiretroviral therapy and liposomal daunorubicin. AIDS (London, England), 2000, Sep-29, Volume: 14, Issue:14 Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Daunorubicin; Didanosine; Drug Therapy, Combination; Herpesvirus 8, Human; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; Sarcoma, Kaposi; Stavudine; Viremia	2000
HIV-1 induction-maintenance at the lymph node level: the "Apollo-97" Study. Journal of acquired immune deficiency syndromes (1999), 2001, Oct-01, Volume: 28, Issue:2 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Biopsy; CD4 Lymphocyte Count; Didanosine; DNA, Viral; Drug Therapy, Combination; Female; France; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lymph Nodes; Lymphocyte Subsets; Lymphocytes; Male; Polymerase Chain Reaction; Ritonavir; RNA, Viral; Saquinavir; Time Factors; Viral Load; Viremia; Virus Replication	2001
[A clinical trial using zidovudine and lamivudine plus indinavir triple therapy in Chinese individuals with human immunodeficiency virus infection]. Zhonghua nei ke za zhi, 2002, Volume: 41, Issue:2 Topics: Adult; Aged; Anti-HIV Agents; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; China; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Lymphocyte Count; Male; Middle Aged; RNA, Viral; Time Factors; Treatment Outcome; Viremia; Zidovudine	2002
A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection. Medical science monitor : international medical journal of experimental and clinical research, 2002, Volume: 8, Issue:4 Topics: Abdominal Pain; Adult; Aged; Alanine Transaminase; Angina Pectoris; Antiviral Agents; Biomarkers; Bronchopneumonia; Colitis, Ulcerative; DNA, Viral; Female; Gastrointestinal Diseases; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Poland; Reverse Transcriptase Inhibitors; Safety; Urinary Tract Infections; Viral Load; Viremia; Virus Replication	2002
Therapeutic vaccination in primary HIV infection, the Quest trial. Vaccine, 2002, May-06, Volume: 20, Issue:15 Topics: AIDS Vaccines; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Carbamates; CD8-Positive T-Lymphocytes; Combined Modality Therapy; Defective Viruses; Dideoxynucleosides; Furans; HIV Infections; Humans; Immunotherapy, Active; Lamivudine; Lymphocyte Count; Sulfonamides; T-Lymphocyte Subsets; Vaccination; Vaccinia virus; Viral Load; Viral Vaccines; Viremia; Zidovudine	2002

Other Studies

102 other study(ies) available for lamivudine and Viremia

Article	Year
Integrase resistance emergence with dolutegravir/lamivudine with prior HIV-1 suppression. The Journal of antimicrobial chemotherapy, 2022, 05-29, Volume: 77, Issue:6 Topics: Drug Resistance, Viral; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; HIV Seropositivity; HIV-1; Humans; Integrases; Lamivudine; Leukocytes, Mononuclear; Male; Oxazines; Piperazines; Pyridones; RNA-Directed DNA Polymerase; Viremia	2022
Recycling Tenofovir in Second-line Antiretroviral Treatment With Dolutegravir: Outcomes and Viral Load Trajectories to 72 weeks. Journal of acquired immune deficiency syndromes (1999), 2023, 04-15, Volume: 92, Issue:5 Topics: Adult; Anti-HIV Agents; Anti-Retroviral Agents; Emtricitabine; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; Humans; Lamivudine; Prospective Studies; Pyridones; Tenofovir; Viral Load; Viremia	2023
Real world use of dolutegravir two drug regimens. AIDS (London, England), 2023, 04-01, Volume: 37, Issue:5 Topics: Anti-HIV Agents; Emtricitabine; Heterocyclic Compounds, 3-Ring; HIV Infections; Homosexuality, Male; Humans; Lamivudine; Male; Middle Aged; Pyridones; Sexual and Gender Minorities; Tablets; Viremia	2023
HIV-1 RNA and DNA Genotyping Drug Resistance Detection in Patients with Low-Level Viremia in Liangshan, China. AIDS research and human retroviruses, 2023, Volume: 39, Issue:8 Topics: Adult; Anti-HIV Agents; Drug Resistance; Drug Resistance, Viral; Emtricitabine; Female; Genotype; HIV Infections; HIV-1; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; RNA; Viremia	2023
Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans. Viruses, 2020, 06-11, Volume: 12, Issue:6 Topics: Adult; Anti-HIV Agents; Antiviral Agents; Coinfection; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Prospective Studies; Tenofovir; Viral Load; Viremia; Young Adult	2020
Prevalence and molecular characterization of hepatitis B virus infection in HIV-infected children in Senegal. Clinics and research in hepatology and gastroenterology, 2021, Volume: 45, Issue:2 Topics: Adolescent; Coinfection; Diagnostic Tests, Routine; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Persistent Infection; Phylogeny; Prevalence; Retrospective Studies; Senegal; Viremia	2021
Drug resistance outcomes of long-term ART with tenofovir disoproxil fumarate in the absence of virological monitoring. The Journal of antimicrobial chemotherapy, 2018, 11-01, Volume: 73, Issue:11 Topics: Adult; Africa South of the Sahara; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Mutation; Reverse Transcriptase Inhibitors; Tenofovir; Time Factors; Treatment Outcome; Viral Load; Viremia	2018
Lamivudine use in pregnant HBsAg-females effectively reduces maternal viremia. Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology, 2019, Volume: 20, Issue:1 Topics: Adult; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunoglobulins; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Reverse Transcriptase Inhibitors; Vaccination; Viral Load; Viremia; Young Adult	2019
Tenofovir-based combination therapy for HIV/HBV co-infection: factors associated with a partial HBV virological response in patients with undetectable HIV viraemia. AIDS (London, England), 2013, Jun-01, Volume: 27, Issue:9 Topics: Adenine; Adult; Anti-HIV Agents; Case-Control Studies; Coinfection; Deoxycytidine; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Lamivudine; Phosphorous Acids; Viremia	2013
Contribution of follicular dendritic cells to persistent HIV viremia. Journal of virology, 2013, Volume: 87, Issue:14 Topics: Dendritic Cells, Follicular; Drug Combinations; HIV Infections; HIV-1; Humans; Kinetics; Lamivudine; Lopinavir; Models, Biological; Ritonavir; Stavudine; Viral Load; Viremia; Virus Release	2013
Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:11 Topics: Animals; Antiviral Agents; Cell Line; DNA, Viral; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Humans; Lamivudine; Male; Mice; Mice, Nude; Microbial Sensitivity Tests; Primary Cell Culture; Pyridines; Pyrimidines; Thiazoles; Viral Core Proteins; Viremia; Virion; Virus Replication	2013
[Outcome of chronic hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive drugs and anti-TNF agents]. Gastroenterologia y hepatologia, 2014, Volume: 37, Issue:1 Topics: Adalimumab; Adenine; Adult; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azathioprine; Crohn Disease; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Lamivudine; Male; Organophosphonates; Tumor Necrosis Factor-alpha; Viral Load; Viremia; Virus Activation	2014
Incidence and risk factors for incomplete HBV DNA suppression in HIV/HBV-co-infected patients initiating tenofovir-based therapy. Journal of viral hepatitis, 2014, Volume: 21, Issue:4 Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Coinfection; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Incidence; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Risk Factors; Tenofovir; Viral Load; Viremia	2014
Reduction of infectivity in chronic hepatitis B virus carriers among healthcare providers and pregnant women by antiviral therapy. Intervirology, 2014, Volume: 57, Issue:3-4 Topics: Adenine; Antiviral Agents; DNA, Viral; Female; Guanine; Health Personnel; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Professional-to-Patient; Infectious Disease Transmission, Vertical; Lamivudine; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Telbivudine; Tenofovir; Thymidine; Viral Load; Viremia	2014
High treatment modification rates with lamivudine therapy in HBV-infected patients with low baseline viremia and early virological response: A multicenter study. Journal of digestive diseases, 2015, Volume: 16, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; DNA, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Function Tests; Male; Middle Aged; Retrospective Studies; Treatment Failure; Treatment Outcome; Viremia; Young Adult	2015
Effectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed Viremia. PloS one, 2015, Volume: 10, Issue:6 Topics: Adult; Anti-Retroviral Agents; Drug Combinations; Emtricitabine; Female; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Randomized Controlled Trials as Topic; RNA, Viral; Tenofovir; Viremia	2015
HBsAg seroconversion after pegylated interferon alfa 2a rescue in a lamivudine-resistant patient with HBeAg-negative chronic hepatitis B and favourable IL28-B genotype. Le infezioni in medicina, 2016, Jun-01, Volume: 24, Issue:2 Topics: Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Interferons; Interleukins; Lamivudine; Male; Polyethylene Glycols; Polymorphism, Single Nucleotide; Recombinant Proteins; Seroconversion; Viremia	2016
[Establishment of an in vivo model for duck hepatitis B virus infection using Hubei duckling]. Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 2008, Volume: 22, Issue:2 Topics: Animals; Animals, Newborn; Disease Models, Animal; DNA, Viral; Ducks; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Hepatitis, Viral, Animal; Lamivudine; Liver; Reverse Transcriptase Inhibitors; Viremia	2008
Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion. Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:3 Topics: Adult; Alanine Transaminase; Antigens, CD; Antiviral Agents; Apoptosis Regulatory Proteins; Biopsy; CD8-Positive T-Lymphocytes; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-gamma; Interleukin-10; Lamivudine; Liver; Longitudinal Studies; Male; Middle Aged; Nucleosides; Programmed Cell Death 1 Receptor; Pyrimidinones; Telbivudine; Thymidine; Treatment Outcome; Viral Load; Viremia	2008
Effect of tenofovir subtraction on HIV plasma viraemia, CD4+ T-cell count and resistance in a patient with baseline K65R and M184V mutations. Antiviral therapy, 2008, Volume: 13, Issue:5 Topics: Adenine; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Male; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; RNA, Viral; Tenofovir; Treatment Outcome; Viremia	2008
Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations. HIV medicine, 2009, Volume: 10, Issue:4 Topics: Adenine; Adult; Aged; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cross-Sectional Studies; Drug Resistance, Viral; Female; Gene Products, pol; Genotype; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Polymerase Chain Reaction; Retrospective Studies; Tenofovir; Viral Load; Viremia	2009
Prevention of vaginal simian immunodeficiency virus transmission in macaques by postexposure prophylaxis with zidovudine, lamivudine and indinavir. AIDS (London, England), 2009, Feb-20, Volume: 23, Issue:4 Topics: Administration, Oral; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Indinavir; Injections, Subcutaneous; Lamivudine; Macaca fascicularis; Sexually Transmitted Diseases, Viral; Simian Acquired Immunodeficiency Syndrome; Vagina; Viral Load; Viremia; Zidovudine	2009
Salvage therapy with tenofovir followed by adefovir maintenance in a cirrhotic patient with a lamivudine resistant HBV flare. Le infezioni in medicina, 2009, Volume: 17, Issue:2 Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Organophosphonates; Reverse Transcriptase Inhibitors; Salvage Therapy; Tenofovir; Viremia	2009
The absence of HIV mutations in cerebrospinal fluid and in peripheral blood mononuclear cells during a regimen containing Trizivir plus tenofovir. Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:4 Topics: Adenine; Anti-HIV Agents; Cohort Studies; Drug Combinations; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Leukocytes, Mononuclear; Mutation; Organophosphonates; Prospective Studies; Tenofovir; Viremia; Zidovudine	2009
Low-abundance HIV species and their impact on mutational profiles in patients with virological failure on once-daily abacavir/lamivudine/zidovudine and tenofovir. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:2 Topics: Adenine; Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Drug Combinations; Drug Resistance, Viral; HIV Infections; HIV-1; Humans; Lamivudine; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Organophosphonates; RNA, Viral; Tenofovir; Treatment Failure; Viremia; Young Adult; Zidovudine	2010
Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemia. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2010, Volume: 42, Issue:12 Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Viral Load; Viremia	2010
Effect of a short-term HAART on SIV load in macaque tissues is dependent on time of initiation and antiviral diffusion. Retrovirology, 2010, Sep-26, Volume: 7 Topics: Administration, Cutaneous; Administration, Oral; Animals; Antiretroviral Therapy, Highly Active; Drug Administration Schedule; HIV Protease Inhibitors; Indinavir; Lamivudine; Macaca fascicularis; Male; Reverse Transcriptase Inhibitors; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Time Factors; Tissue Distribution; Viremia; Zidovudine	2010
Lamivudine resistance mutations in European patients with hepatitis B and patients co-infected with HIV and hepatitis B. Journal of medical virology, 2011, Volume: 83, Issue:11 Topics: Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Mutation, Missense; Retrospective Studies; Treatment Failure; Viral Load; Viremia	2011
Strong antiviral activity of the new l-hydroxycytidine derivative, l-Hyd4FC, in HBV-infected human chimeric uPA/SCID mice. Antiviral therapy, 2012, Volume: 17, Issue:4 Topics: Animals; Antiviral Agents; Chimera; Cytidine; DNA, Viral; Hepatitis B; Humans; Lamivudine; Mice; Mice, SCID; Molecular Structure; Urokinase-Type Plasminogen Activator; Viremia; Zalcitabine	2012
Evolution of adefovir-resistant HBV polymerase gene variants after switching to tenofovir disoproxil fumarate monotherapy. Antiviral therapy, 2012, Volume: 17, Issue:6 Topics: Adenine; Adult; Aged; Antiviral Agents; Cloning, Molecular; DNA, Viral; Drug Resistance, Viral; Drug Substitution; Escherichia coli; Evolution, Molecular; Female; Follow-Up Studies; Gene Products, pol; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Tenofovir; Viremia	2012
Outcome of lamivudine-resistant chronic hepatitis B after up to 5 years of combination therapy with adefovir. Antiviral therapy, 2012, Volume: 17, Issue:7 Topics: Adenine; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Predictive Value of Tests; Statistics, Nonparametric; Time Factors; Treatment Outcome; Viremia; Young Adult	2012
Development of drug resistance in HIV-1 patients receiving a combination of stavudine, lamivudine and efavirenz. International journal of antimicrobial agents, 2002, Volume: 20, Issue:3 Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Resistance, Viral; Genes, Viral; HIV Infections; HIV-1; Humans; Lamivudine; Mutation; Oxazines; RNA, Viral; Stavudine; Viral Load; Viremia	2002
[Measuring the HIV viral load with LCx (Abbott): importance for the therapeutic follow-up of 3 patients infected by type O HIV]. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2003, Volume: 10, Issue:2 Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Resistance, Multiple, Viral; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Oxazines; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Viral Load; Viremia; Zidovudine	2003
A case of relapsing Guillain-Barré syndrome associated with exacerbation of chronic hepatitis B virus hepatitis. Journal of neurovirology, 2003, Volume: 9, Issue:3 Topics: Aged; Antigen-Antibody Complex; DNA, Viral; Guillain-Barre Syndrome; Hepatitis B Antibodies; Hepatitis B Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lamivudine; Liver Function Tests; Male; Prednisolone; Recurrence; Time Factors; Viremia; Virus Replication	2003
Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV-HBV co-infected individuals. AIDS (London, England), 2003, Jul-25, Volume: 17, Issue:11 Topics: Adult; Aged; CD4 Lymphocyte Count; Chronic Disease; Cross-Sectional Studies; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Mutation; Prevalence; Regression Analysis; Retrospective Studies; Reverse Transcriptase Inhibitors; Statistics, Nonparametric; Viremia	2003
pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy. AIDS research and human retroviruses, 2003, Volume: 19, Issue:7 Topics: Adolescent; Adult; Africa, Western; Amino Acid Sequence; Amino Acid Substitution; Anti-HIV Agents; Codon; Drug Resistance, Multiple, Viral; Evolution, Molecular; Female; Genes, pol; Genetic Variation; HIV Infections; HIV Protease Inhibitors; HIV-1; HIV-2; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Nelfinavir; Prospective Studies; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Sequence Alignment; Sequence Homology, Amino Acid; Sweden; Treatment Failure; Viremia; Zidovudine	2003
Use of adefovir in the treatment of the chronic hepatitis B virus infection with resistance to lamivudine. Transplantation proceedings, 2003, Volume: 35, Issue:5 Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Patient Selection; Recurrence; Treatment Failure; Viremia	2003
Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model. Antiviral research, 2004, Volume: 63, Issue:2 Topics: Adenine; Administration, Oral; Amino Acid Motifs; Amino Acid Substitution; Animals; Antiviral Agents; Disease Models, Animal; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Virus, Woodchuck; Lamivudine; Marmota; Mutation, Missense; Organophosphonates; Protein Structure, Tertiary; Viremia; Virus Replication	2004
Prompt relapse of viremia after lamivudine discontinuation in e-minus chronic hepatitis B patients completely responders during 5 years of therapy. Journal of hepatology, 2004, Volume: 41, Issue:3 Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Recurrence; Viremia	2004
Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine. The Journal of infectious diseases, 2005, Apr-01, Volume: 191, Issue:7 Topics: Adenine; Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; DNA, Viral; Female; HIV; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Multivariate Analysis; Organophosphonates; Oxazines; RNA, Viral; Stavudine; Tenofovir; Viremia	2005
Preliminary study on the efficacy and safety of lamivudine and interferon alpha therapy in decreasing serum HBV DNA level in HBV positive transgenic mice during pregnancy. Journal of medical virology, 2005, Volume: 76, Issue:2 Topics: Animals; Antiviral Agents; Disease Models, Animal; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Interferon-alpha; Lamivudine; Mice; Mice, Transgenic; Pregnancy; Pregnancy Complications, Infectious; Viremia	2005
Adherence to trizivir and tenofovir as a simplified salvage regimen is associated with suppression of viraemia and a decreased cholesterol. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cholesterol; Dideoxynucleosides; Drug Combinations; Erythrocyte Indices; Humans; Lamivudine; Organophosphonates; Patient Compliance; Salvage Therapy; Tenofovir; Viral Load; Viremia; Zidovudine	2005
Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus. Hepatology (Baltimore, Md.), 2005, Volume: 42, Issue:5 Topics: Animals; Cell Line, Tumor; Chimera; DNA, Viral; Genetic Engineering; Hepatitis B; Hepatitis B virus; Hepatocytes; Histocytochemistry; Humans; Lamivudine; Liver; Mice; Mutation; Time Factors; Viremia	2005
Detection and quantification of proviral HIV-1 184 M/V in circulating CD4(+) T cells of patients on HAART with a viremia less than 1,000 copies/ml. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2005, Volume: 34, Issue:4 Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Cross-Sectional Studies; DNA, Viral; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Mutation; Proviruses; Viremia	2005
Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy. AIDS (London, England), 2006, Apr-04, Volume: 20, Issue:6 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Drug Resistance, Viral; Genes, pol; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Immune Tolerance; Lamivudine; Male; Middle Aged; Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Viral Envelope Proteins; Viral Load; Viremia	2006
Variant of hepatitis B virus with primary resistance to adefovir. The New England journal of medicine, 2006, Apr-27, Volume: 354, Issue:17 Topics: Adenine; Amino Acid Sequence; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Tenofovir; Viremia	2006
Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia. AIDS (London, England), 2006, May-12, Volume: 20, Issue:8 Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Prospective Studies; Reverse Transcriptase Inhibitors; Tenofovir; Viral Load; Viremia; Zidovudine	2006
COBAS AmpliPrep-COBAS TaqMan hepatitis B virus (HBV) test: a novel automated real-time PCR assay for quantification of HBV DNA in plasma. Journal of clinical microbiology, 2007, Volume: 45, Issue:3 Topics: Adenine; Antiviral Agents; Automation; Biopsy; DNA, Viral; Drug Resistance, Viral; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Nucleic Acid Amplification Techniques; Organophosphonates; Polymerase Chain Reaction; Sensitivity and Specificity; Taq Polymerase; Viremia	2007
Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance. Gastroenterology, 2007, Volume: 132, Issue:2 Topics: Adult; Amino Acid Substitution; Cell Line; DNA, Viral; Female; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunoenzyme Techniques; Lamivudine; Male; Middle Aged; Mutagenesis, Site-Directed; Mutation; Polymerase Chain Reaction; Predictive Value of Tests; Prognosis; Protein Precursors; Radioimmunoassay; Reagent Kits, Diagnostic; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Time Factors; Transfection; Treatment Outcome; Viremia	2007
Evolution of viral load and changes of polymerase and precore/core promoter sequences in lamivudine-resistant hepatitis B virus during adefovir therapy. Journal of medical virology, 2007, Volume: 79, Issue:7 Topics: Adenine; Adult; Antiviral Agents; Base Sequence; DNA Mutational Analysis; DNA Primers; DNA, Viral; Drug Resistance, Viral; Evolution, Molecular; Female; Gene Products, pol; Genes, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Promoter Regions, Genetic; Viral Core Proteins; Viremia	2007
Treatment of chronic hepatitis B with lamivudine in renal transplant recipients. The International journal of artificial organs, 2007, Volume: 30, Issue:4 Topics: Adult; Alanine Transaminase; Antiviral Agents; Biopsy; DNA, Viral; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C; Humans; Immunosuppression Therapy; Kidney Transplantation; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Remission Induction; Renal Dialysis; Reverse Transcriptase Inhibitors; Time Factors; Viremia	2007
Dynamics of 103K/N and 184M/V HIV-1 drug resistant populations: relative comparison in plasma virus RNA versus CD45RO+T cell proviral DNA. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2007, Volume: 39, Issue:3 Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Leukocyte Common Antigens; Mutation; Nevirapine; Nucleic Acid Amplification Techniques; Proviruses; Reverse Transcriptase Inhibitors; RNA, Viral; T-Lymphocytes; Viremia	2007
Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment. The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:2 Topics: Adenine; Adult; Aged; Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Nucleosides; Nucleotides; Organophosphonates; Reverse Transcriptase Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Viremia	2007
[Update on HIV infection in Mayotte]. Medecine tropicale : revue du Corps de sante colonial, 2007, Volume: 67, Issue:2 Topics: Adult; Anti-HIV Agents; Comoros; Dideoxynucleosides; Drug Combinations; Female; Heterosexuality; HIV Infections; HIV Seropositivity; Homosexuality; Humans; Lamivudine; Male; Middle Aged; Transfusion Reaction; Viremia; Zidovudine	2007
Prednisolone mediated suppression of HIV-1 viral load strongly correlates with C-C chemokine CCL2: In vivo and in vitro findings. Clinical immunology (Orlando, Fla.), 2007, Volume: 125, Issue:1 Topics: Alkynes; Anti-HIV Agents; Anti-Inflammatory Agents; Benzoxazines; Chemokine CCL2; Cyclopropanes; Drug Resistance, Viral; Flow Cytometry; Gene Expression; HIV Infections; HIV-1; Humans; In Vitro Techniques; Interleukin-8; Lamivudine; Male; Prednisolone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha; Uveitis; Viral Load; Viremia; Zidovudine	2007
DNA vaccination in combination or not with lamivudine treatment breaks humoral immune tolerance and enhances cccDNA clearance in the duck model of chronic hepatitis B virus infection. The Journal of general virology, 2008, Volume: 89, Issue:Pt 5 Topics: Animals; DNA, Viral; Ducks; Follow-Up Studies; Hepadnaviridae Infections; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Virus, Duck; Hepatitis, Viral, Animal; Immune Tolerance; Lamivudine; Liver; Vaccines, DNA; Viral Envelope Proteins; Viremia	2008
Viral dynamics in hepatitis B virus infection. Proceedings of the National Academy of Sciences of the United States of America, 1996, Apr-30, Volume: 93, Issue:9 Topics: Alanine Transaminase; Antiviral Agents; Dose-Response Relationship, Drug; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; HIV Infections; Humans; Kinetics; Lamivudine; Models, Biological; Regression Analysis; Reverse Transcriptase Inhibitors; Time Factors; Viremia; Virus Replication; Zalcitabine	1996
Human immunodeficiency virus type 1 kinetics in lymph nodes compared with plasma. The Journal of infectious diseases, 1996, Volume: 174, Issue:2 Topics: Antiviral Agents; Biopsy; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Kinetics; Lamivudine; Lymph Nodes; RNA, Viral; Viremia; Zalcitabine; Zidovudine	1996
Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology (Baltimore, Md.), 1996, Volume: 24, Issue:3 Topics: Adult; Antiviral Agents; Base Sequence; Conserved Sequence; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Molecular Probes; Molecular Sequence Data; Mutation; Postoperative Complications; Recurrence; RNA, Viral; Viremia	1996
An update on HIV/AIDS. Journal of the American Dental Association (1939), 1996, Volume: 127, Issue:9 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; United States; Viremia; Zidovudine	1996
Effect of antiretroviral combination therapy (zidovudine/didanosine or zidovudine/lamivudine) on quantitative plasma human immunodeficiency virus-ribonucleic acid in children and adolescents infected with human immunodeficiency virus. The Journal of pediatrics, 1997, Volume: 130, Issue:2 Topics: Adolescent; AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant; Lamivudine; Male; RNA, Viral; Time Factors; Viral Load; Viremia; Zidovudine	1997
Decay characteristics of HIV-1-infected compartments during combination therapy. Nature, 1997, May-08, Volume: 387, Issue:6629 Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Drug Therapy, Combination; Half-Life; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Isoquinolines; Lamivudine; Leukocytes, Mononuclear; Macrophages; Mathematics; Models, Biological; Nelfinavir; Proviruses; Reverse Transcriptase Inhibitors; RNA, Viral; Sulfonic Acids; Viral Load; Viremia; Virus Latency; Zidovudine	1997
Quantification of HIV-1 viral load in lymphoid and blood cells: assessment during four-drug combination therapy. AIDS (London, England), 1997, Volume: 11, Issue:7 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; DNA, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Leukocytes, Mononuclear; Lymph Nodes; Male; Polymerase Chain Reaction; RNA, Viral; Saquinavir; Viral Load; Viremia; Zidovudine	1997
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science (New York, N.Y.), 1997, Nov-14, Volume: 278, Issue:5341 Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Coculture Techniques; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Immunologic Memory; Indinavir; Lamivudine; Lymphocyte Activation; Mutation; RNA, Viral; T-Lymphocyte Subsets; Viral Load; Viremia; Virus Activation; Virus Latency; Virus Replication; Zidovudine	1997
thy/liv-SCID-hu mice: a system for investigating the in vivo effects of multidrug therapy on plasma viremia and human immunodeficiency virus replication in lymphoid tissues. The Journal of infectious diseases, 1998, Volume: 177, Issue:2 Topics: Animals; Anti-HIV Agents; Chronic Disease; Drug Resistance, Microbial; Drug Therapy, Combination; Fetal Tissue Transplantation; Flow Cytometry; HIV Infections; HIV-1; Lamivudine; Leukocytes, Mononuclear; Liver Transplantation; Mice; Mice, SCID; Recurrence; Ritonavir; RNA, Viral; Saquinavir; Thymus Gland; Viremia; Zidovudine	1998
Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma. AIDS (London, England), 1998, May-07, Volume: 12, Issue:7 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Didanosine; Dideoxynucleosides; Drug Therapy, Combination; Female; Herpesvirus 8, Human; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Sarcoma, Kaposi; Stavudine; Treatment Outcome; Viral Load; Viremia; Zalcitabine; Zidovudine	1998
[HIV infection: DuPont Pharma presents the results of its antiretroviral agent]. Allergie et immunologie, 1998, Volume: 30, Issue:4 Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Evaluation; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Lamivudine; Oxazines; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viremia; Zidovudine	1998
Pharmacodynamics of (-)-beta-2',3'-dideoxy-3'-thiacytidine in chronically virus-infected woodchucks compared to its pharmacodynamics in humans. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:11 Topics: Animals; Dose-Response Relationship, Drug; Female; Hepatitis B virus; Hepatitis B Virus, Woodchuck; Humans; Lamivudine; Male; Marmota; Viremia	1998
Expression of CD38 on CD8 T cells predicts maintenance of high viraemia in HAART-treated HIV-1-infected children. Highly active antiretroviral therapy. Lancet (London, England), 1998, Dec-12, Volume: 352, Issue:9144 Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Antigens, CD; Antigens, Differentiation; CD8-Positive T-Lymphocytes; Child; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Membrane Glycoproteins; NAD+ Nucleosidase; Stavudine; Viremia	1998
The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents. Hepatology (Baltimore, Md.), 1999, Volume: 29, Issue:2 Topics: Animals; Antibodies, Viral; Antiviral Agents; Deoxycytidine; Disease Models, Animal; DNA, Viral; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney; Lamivudine; Liver; Liver Transplantation; Mice; Mice, Inbred NOD; Mice, SCID; Polymerase Chain Reaction; RNA, Messenger; Serum Albumin; Viremia	1999
Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy. Journal of virology, 1999, Volume: 73, Issue:8 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Cytotoxicity, Immunologic; Drug Therapy, Combination; Epitopes, T-Lymphocyte; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Immunologic Memory; Indinavir; Lamivudine; Longitudinal Studies; Reverse Transcriptase Inhibitors; Stavudine; T-Lymphocytes, Cytotoxic; Viral Load; Viremia; Zidovudine	1999
Antiviral effect of AZT versus stavudine in combination with lamivudine and indinavir in the context of a populational study. Journal of acquired immune deficiency syndromes (1999), 1999, Aug-01, Volume: 21, Issue:4 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Male; Stavudine; Viremia; Zidovudine	1999
Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection. AIDS (London, England), 1999, Dec-03, Volume: 13, Issue:17 Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Adult; Anti-HIV Agents; Antigens, CD; Antigens, Differentiation; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; HIV Infections; HIV-1; HLA-DR Antigens; Humans; Indinavir; Lamivudine; Lymphocyte Activation; Male; Membrane Glycoproteins; NAD+ Nucleosidase; Palatine Tonsil; Proviruses; T-Lymphocyte Subsets; Time Factors; Viremia; Virus Replication; Zidovudine	1999
Quantitation of human immunodeficiency virus type 1 group O load in plasma by measuring reverse transcriptase activity. Journal of clinical microbiology, 2000, Volume: 38, Issue:1 Topics: Adult; Anti-HIV Agents; Female; Guinea; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Spain; Stavudine; Viral Load; Viremia	2000
Significance testing of clinical data using virus dynamics models with a Markov chain Monte Carlo method: application to emergence of lamivudine-resistant hepatitis B virus. Proceedings. Biological sciences, 1999, Dec-07, Volume: 266, Issue:1436 Topics: Antiviral Agents; Drug Resistance, Microbial; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Markov Chains; Models, Theoretical; Monte Carlo Method; Mutation; Time Factors; Viremia; Virus Replication	1999
Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonality. Blood, 2000, Mar-01, Volume: 95, Issue:5 Topics: Acute Disease; Anti-HIV Agents; Clone Cells; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Lamivudine; Lymphocyte Activation; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Saquinavir; T-Lymphocytes, Cytotoxic; Viremia; Zidovudine	2000
Normalization of CD4+ cell numbers and reduced levels of memory CD8+ cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection. AIDS research and human retroviruses, 2000, Feb-10, Volume: 16, Issue:3 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Immunologic Memory; Indinavir; Lamivudine; Male; Palatine Tonsil; Reverse Transcriptase Inhibitors; T-Lymphocyte Subsets; Time Factors; Viremia; Zidovudine	2000
Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA. The Journal of clinical investigation, 2000, Volume: 105, Issue:6 Topics: Adult; Anti-HIV Agents; Carbamates; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cohort Studies; Dideoxynucleosides; Furans; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Lymph Nodes; Nelfinavir; Reverse Transcriptase Inhibitors; RNA, Viral; Saquinavir; Stavudine; Sulfonamides; Time Factors; Viral Load; Viremia; Zidovudine	2000
Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks. Antiviral research, 2000, Volume: 45, Issue:1 Topics: 2-Aminopurine; Animals; Antiviral Agents; Carrier State; Disease Models, Animal; Drug Therapy, Combination; Famciclovir; Hepatitis B Virus, Woodchuck; Hepatitis B, Chronic; Lamivudine; Marmota; Prodrugs; Reverse Transcriptase Inhibitors; Viremia; Virus Replication	2000
HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients. Transplantation, 2000, May-27, Volume: 69, Issue:10 Topics: Adult; Aged; Amino Acid Sequence; Base Sequence; DNA, Viral; Drug Resistance, Microbial; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Renal Dialysis; Reverse Transcriptase Inhibitors; Viremia	2000
Onset of HIV-1 antibody production after highly active antiretroviral therapy in a seronegative HIV-1-infected child. AIDS (London, England), 2000, Jun-16, Volume: 14, Issue:9 Topics: Anti-HIV Agents; Antibody Formation; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Antibodies; HIV Infections; HIV Seronegativity; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Nelfinavir; Pregnancy; Pregnancy Complications, Infectious; Viremia; Zidovudine	2000
Lamivudine in the last 4 weeks of pregnancy to prevent perinatal transmission in highly viremic chronic hepatitis B patients. Journal of hepatology, 2000, Volume: 32, Issue:6 Topics: Female; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Reverse Transcriptase Inhibitors; Viremia	2000
Enhanced antiviral benefit of combination therapy with lamivudine and alpha interferon against WHV replication in chronic carrier woodchucks. Antiviral therapy, 2000, Volume: 5, Issue:2 Topics: Animals; Antiviral Agents; Carrier State; Drug Therapy, Combination; Female; Hepatitis B Virus, Woodchuck; Hepatitis B, Chronic; Humans; Interferon Type I; Interferon-alpha; Lamivudine; Marmota; Recombinant Proteins; RNA, Viral; Viremia; Virus Replication	2000
Lamivudine as an alternative therapy for interferon-resistant chronic hepatitis B and the characteristics of hepatitis B virus: a case report. The Tohoku journal of experimental medicine, 2000, Volume: 191, Issue:4 Topics: Adult; Amino Acid Motifs; Amino Acid Sequence; Antiviral Agents; Base Sequence; DNA Primers; Drug Resistance; Hepatitis B Core Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Male; Point Mutation; Viremia	2000
Highly active antiretroviral therapy normalizes the potential for MIP-1alpha production in HIV infection. The Journal of infection, 2000, Volume: 41, Issue:3 Topics: Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cells, Cultured; Chemokine CCL3; Chemokine CCL4; Chemokine CCL5; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; HIV Infections; HIV-1; Humans; Lamivudine; Lymphocyte Count; Lymphocytes; Macrophage Inflammatory Proteins; Male; Nelfinavir; Stavudine; Viral Load; Viremia	2000
Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection. Proceedings of the National Academy of Sciences of the United States of America, 2001, Jan-16, Volume: 98, Issue:2 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Depression, Chemical; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Hydroxyurea; Immunity, Cellular; Indinavir; Lamivudine; Lymphocyte Count; Male; Middle Aged; Nelfinavir; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Treatment Refusal; Viral Load; Viremia; Zidovudine	2001
Changes in host cell molecules acquired by circulating HIV-1 in patients treated with highly active antiretroviral therapy and interleukin-2. AIDS (London, England), 2001, Jan-05, Volume: 15, Issue:1 Topics: Anti-HIV Agents; Antigens, CD; Antiretroviral Therapy, Highly Active; B7-2 Antigen; CD4 Lymphocyte Count; CD58 Antigens; Fas Ligand Protein; HIV Infections; HIV Protease Inhibitors; HIV-1; HLA-DR Antigens; Humans; Indinavir; Interleukin-2; L-Selectin; Lamivudine; Leukocyte Common Antigens; Membrane Glycoproteins; Membrane Proteins; Reverse Transcriptase Inhibitors; Stavudine; Viremia; Virion	2001
Quantification of HIV-1 proviral DNA in patients with undetectable plasma viremia over long-term highly active antiretroviral therapy. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2000, Volume: 4, Issue:4 Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; DNA, Viral; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Polymerase Chain Reaction; Proviruses; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Viremia; Zidovudine	2000
Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:4 Topics: Animals; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Circular; DNA, Viral; Drug Administration Schedule; Hepatitis B Virus, Woodchuck; Hepatitis B, Chronic; Lamivudine; Liver; Marmota; Skin Pigmentation; Viremia; Virus Replication; Zalcitabine	2001
Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years. The Journal of infectious diseases, 2001, May-01, Volume: 183, Issue:9 Topics: Cohort Studies; DNA, Viral; Female; Genitalia; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Longitudinal Studies; Lymph Nodes; Male; Molecular Sequence Data; Randomized Controlled Trials as Topic; RNA, Viral; Time Factors; Viral Load; Viremia; Virus Replication; Zidovudine	2001
Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2001, Volume: 20, Issue:2 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; DNA, Viral; Female; Genitalia, Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Longitudinal Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Statistics, Nonparametric; Viral Load; Viremia; Virus Shedding; Zidovudine	2001
Impact of antiretroviral therapy on hepatitis C viraemia in HIV-infected patients. Antiviral therapy, 1996, Volume: 1, Issue:3 Topics: Anti-HIV Agents; Drug Therapy, Combination; Hepatitis C; HIV Infections; Humans; Lamivudine; RNA, Viral; Viremia; Zidovudine	1996
Antiretroviral drug resistance. AIDS clinical care, 1995, Volume: 7, Issue:8 Topics: Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; RNA, Viral; Stavudine; Viremia; Zalcitabine; Zidovudine	1995
Conference looks at HIV drug resistance. GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1995, Volume: 9, Issue:9 Topics: Antiviral Agents; Carbamates; CD4 Lymphocyte Count; Drug Resistance, Microbial; Furans; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Sulfonamides; Thiazoles; Valine; Viremia; Zalcitabine; Zidovudine	1995
Residual human immunodeficiency virus type 1 infection in lymphoid tissue during highly active antiretroviral therapy: quantitation and virus characterization. AIDS research and human retroviruses, 2001, May-01, Volume: 17, Issue:7 Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Disease Progression; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Longitudinal Studies; Lymphoid Tissue; Phenotype; Proviruses; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Viral Load; Viremia; Virus Replication; Zidovudine	2001
Prevalence and predictive value of intermittent viremia with combination hiv therapy. JAMA, 2001, Jul-11, Volume: 286, Issue:2 Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Resistance, Microbial; HIV; HIV Infections; Humans; Indinavir; Lamivudine; Predictive Value of Tests; Prevalence; Proportional Hazards Models; Retrospective Studies; RNA, Viral; Viral Load; Viremia; Virus Replication; Zidovudine	2001
Efficacy and tolerability of long-term therapy using high lamivudine doses for the treatment of chronic hepatitis B. Journal of gastroenterology, 2001, Volume: 36, Issue:7 Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Child; DNA, Viral; Drug Administration Schedule; Drug Resistance, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome; Viremia	2001
T-helper cell response to woodchuck hepatitis virus antigens after therapeutic vaccination of chronically-infected animals treated with lamivudine. Journal of hepatology, 2001, Volume: 35, Issue:1 Topics: Animals; Antigens, Viral; Chronic Disease; Hepatitis B; Hepatitis B Virus, Woodchuck; Immunotherapy, Active; Lamivudine; Liver; Marmota; Reverse Transcriptase Inhibitors; T-Lymphocytes, Helper-Inducer; Viral Load; Viremia	2001
Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection. AIDS (London, England), 2002, Mar-08, Volume: 16, Issue:4 Topics: Adult; Anti-HIV Agents; Antigens, CD; Antiretroviral Therapy, Highly Active; Biomarkers; Carbamates; CD48 Antigen; CD8-Positive T-Lymphocytes; Dideoxynucleosides; Female; Furans; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lymphocyte Count; Male; Middle Aged; Reverse Transcriptase Inhibitors; Sulfonamides; T-Lymphocyte Subsets; Treatment Outcome; Viral Load; Viremia; Zidovudine	2002
Switching to zidovudine plus lamivudine plus abacavir maintains viral suppression in patients with high viral load before antiretroviral therapy: a retrospective clinical cohort analysis. AIDS (London, England), 2002, May-03, Volume: 16, Issue:7 Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Dideoxynucleosides; Drug Evaluation; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; London; Retrospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load; Viremia; Zidovudine	2002
Needlestick transmission of hepatitis C. JAMA, 2002, May-08, Volume: 287, Issue:18 Topics: Accidents, Occupational; Acute Disease; Adult; Anti-HIV Agents; Antiviral Agents; Asthenia; Exanthema; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Interferon alpha-2; Interferon-alpha; Internship and Residency; Lamivudine; Needlestick Injuries; Nelfinavir; Occupational Exposure; Physicians; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Viremia; Zidovudine	2002
Course of virologic breakthroughs under long-term lamivudine in HBeAg-negative precore mutant HBV liver disease. Hepatology (Baltimore, Md.), 2002, Volume: 36, Issue:1 Topics: Adult; Aged; Alanine Transaminase; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kinetics; Lamivudine; Liver; Male; Middle Aged; Mutation; Polymerase Chain Reaction; Recurrence; Remission Induction; Viremia	2002